Wharton's Jelly | sciencenewsnet.in

Breaking News

Penn Study Highlights Inconsistencies of Genetic Markers for Predicting Heart Disease

New study shows how salmonella tricks gut defenses to cause infection

How ecDNA Fuels Cancer by Breaking the Laws of Biology

Creating a spatial map of the sea

Much Ado About Vacuum

Researchers Uncover Achilles Heel of Antibiotic-Resistant Bacteria

HSS Appoints Daphne A. Scott, MD, Chief of Primary Sports Medicine

Study: Coronary Function Testing Improves Diagnosis of Heart Disease in Women

Multi-disciplinary teams respond to recent hurricanes to measure real time impacts of storm surge, waves

New pathways for Alzheimer’s prevention

18 Nov, 2024

REGENATIVE LABS’ LATEST PUBLISHED STUDY DEMONSTRATES THE SAFETY AND EFFICACY OF WHARTON’S JELLY CONNECTIVE TISSUE ALLOGRAFT FOR ROTATOR CUFF TEARS

April 4, 2024 sarah JonasResearch Results

Regenative Labs (Regenative), a leading HCT/P manufacturer, announces the publication of a study exhibiting the safety and efficacy of Wharton’s Jelly connective tissue allograft for rotator cuff tears.